Show simple item record

The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma

dc.contributor.authorBeydogan, Alisa Bahar
dc.contributor.authorBolkent, Sema
dc.date.accessioned2021-03-05T08:45:43Z
dc.date.available2021-03-05T08:45:43Z
dc.date.issued2016
dc.identifier.citationBeydogan A. B. , Bolkent S., "The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma", PHARMACOLOGICAL REPORTS, cilt.68, ss.543-549, 2016
dc.identifier.issn1734-1140
dc.identifier.otherav_9a85f165-1929-4250-bb75-7d1584a37078
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/103876
dc.identifier.urihttps://doi.org/10.1016/j.pharep.2015.12.003
dc.description.abstractBackground: Ehrlich ascites carcinoma is the one of the animal cancer models having high malignancy and rapid growth resistance. Silibin has reported to be an antioxidant in previous studies. We aimed to investigate the effects of silibin on mouse liver with Ehrlich ascites tumor (EAT) cells in different time periods.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleThe effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma
dc.typeMakale
dc.relation.journalPHARMACOLOGICAL REPORTS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume68
dc.identifier.issue3
dc.identifier.startpage543
dc.identifier.endpage549
dc.contributor.firstauthorID227702


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record